Zhujiang Dai1,2,#, Xiaoyong Ge1,2,#, Wenbo Tang1,2, Chen-Ying Liu1,2, Yun Liu1,2,*, Zhongchuan Wang1,2,*
Oncology Research, Vol.33, No.12, pp. 4113-4143, 2025, DOI:10.32604/or.2025.068473
- 27 November 2025
Abstract Objective: The plastic role of regulatory factor X1 (RFX1) in colon cancer progression and its impact on the tumor microenvironment remain poorly understood. The study aimed to clarify the molecular and clinical role of RFX1 in colon cancer. Methods: We classified colon cancers into subgroups with high and low RFX1 expression and characterized their immune profiles, mutational profiles, cancer immunotherapy and drug sensitivity. By combining RFX1 expression with persistent tumor mutational burden, we proposed a novel nomogram clinical prediction model and validated its predictive performance, and the correlation between high expression and poor prognosis. Results: Compared… More >
Graphic Abstract